Lisa Miller | Senior Director of Investor Relations |
Rick Hawkins | Chief Executive Officer and Chairman |
Lori Lawley | Chief Financial Officer |
John McKew | President and Chief Scientific Officer |
Duke Pitukcheewanont | Senior Vice President of Global Clinical Development and Medical Affairs |
Yasmeen Rahimi | Piper Sandler |
Leland Gershell | Oppenheimer |
Ed White | H.C. Wainwright |
Catherine Novack | Jones Trading |
Pete Stavropoulos | Cantor Fitzgerald |
Good afternoon, and welcome to Lumos Pharma's Q2 2023 Financial Results Conference Call. Currently, all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instructions will follow at that time.
As a reminder, this conference call is being recorded.
I'll now turn the call over to Lisa Miller, Senior Director of Investor Relations.